JP Morgan Chase
HAE icon

JP Morgan Chase’s Haemonetics HAE Stock Holding History

JP Morgan Chase’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.1M Buy
328,909
+72,356
+28% +$4.71M ﹤0.01% 2161
2025
Q4 		$20.6M Sell
256,553
-22,425
-8% -$1.51M ﹤0.01% 2043
2025
Q3 		$13.6M Buy
278,978
+102,704
+58% +$6.36M ﹤0.01% 2451
2025
Q2 		$13.2M Sell
176,274
-7,520
-4% -$498K ﹤0.01% 2313
2025
Q1 		$11.7M Buy
183,794
+10,413
+6% +$708K ﹤0.01% 2402
2024
Q4 		$13.5M Buy
173,381
+18,658
+12% +$1.5M ﹤0.01% 2414
2024
Q3 		$12.4M Sell
154,723
-2,096
-1% -$169K ﹤0.01% 2419
2024
Q2 		$13M Sell
156,819
-36,746
-19% -$3.23M ﹤0.01% 2222
2024
Q1 		$16.5M Buy
193,565
+17,226
+10% +$1.35M ﹤0.01% 2041
2023
Q4 		$15.1M Buy
176,339
+4,962
+3% +$429K ﹤0.01% 2082
2023
Q3 		$15.4M Sell
171,377
-16,301
-9% -$1.46M ﹤0.01% 1888
2023
Q2 		$16M Buy
187,678
+9,787
+6% +$827K ﹤0.01% 1868
2023
Q1 		$14.7M Buy
177,891
+24,686
+16% +$2M ﹤0.01% 1925
2022
Q4 		$12M Buy
153,205
+6,752
+5% +$543K ﹤0.01% 2092
2022
Q3 		$10.8M Buy
146,453
+11,828
+9% +$849K ﹤0.01% 2092
2022
Q2 		$8.77M Sell
134,625
-454
-0.3% -$26.9K ﹤0.01% 2278
2022
Q1 		$8.54M Buy
135,079
+26,017
+24% +$1.41M ﹤0.01% 2532
2021
Q4 		$5.78M Sell
109,062
-4,091
-4% -$249K ﹤0.01% 2940
2021
Q3 		$7.99M Sell
113,153
-13,404
-11% -$846K ﹤0.01% 2603
2021
Q2 		$8.43M Buy
126,557
+23,340
+23% +$1.65M ﹤0.01% 2573
2021
Q1 		$11.5M Buy
103,217
+8,988
+10% +$1.11M ﹤0.01% 2246
2020
Q4 		$11.2M Buy
94,229
+6,010
+7% +$647K ﹤0.01% 2121
2020
Q3 		$7.66M Buy
88,219
+27,491
+45% +$2.4M ﹤0.01% 2243
2020
Q2 		$5.44M Sell
60,728
-31,620
-34% -$3.19M ﹤0.01% 2397
2020
Q1 		$9.2M Sell
92,348
-129,545
-58% -$14M ﹤0.01% 1815
2019
Q4 		$25.5M Sell
221,893
-64,307
-22% -$7.78M ﹤0.01% 1402
2019
Q3 		$36.1M Buy
286,200
+132,292
+86% +$16.8M 0.01% 1133
2019
Q2 		$18.4M Sell
153,908
-74,824
-33% -$7.36M ﹤0.01% 1627
2019
Q1 		$20M Sell
228,732
-52,703
-19% -$4.79M ﹤0.01% 1536
2018
Q4 		$28.2M Sell
281,435
-428,418
-60% -$45M 0.01% 1232
2018
Q3 		$81.3M Buy
709,853
+203,656
+40% +$21.1M 0.02% 792
2018
Q2 		$45.4M Sell
506,197
-34,433
-6% -$2.91M 0.01% 1024
2018
Q1 		$39.6M Buy
540,630
+401,164
+288% +$27.5M 0.01% 1066
2017
Q4 		$8.1M Buy
139,466
+53,904
+63% +$2.84M ﹤0.01% 2291
2017
Q3 		$3.7M Buy
85,562
+44,128
+107% +$1.83M ﹤0.01% 2781
2017
Q2 		$1.64M Sell
41,434
-21,910
-35% -$900K ﹤0.01% 3166
2017
Q1 		$2.57M Sell
63,344
-77,842
-55% -$3.04M ﹤0.01% 2888
2016
Q4 		$5.67M Buy
141,186
+106,361
+305% +$4.01M ﹤0.01% 2345
2016
Q3 		$1.26M Buy
34,825
+206
+0.6% +$7.07K ﹤0.01% 3023
2016
Q2 		$1M Buy
34,619
+201
+0.6% +$6.08K ﹤0.01% 3176
2016
Q1 		$1.2M Buy
34,418
+34,169
+13,722% +$1.1M ﹤0.01% 2985
2015
Q4 		$8K Buy
+249
New +$8.08K ﹤0.01% 4252
2014
Q4 		– Sell
-9,221
Closed -$322K – 4271
2014
Q3 		$322K Sell
9,221
-55,516
-86% -$1.98M ﹤0.01% 3821
2014
Q2 		$2.29M Buy
64,737
+25,877
+67% +$864K ﹤0.01% 2458
2014
Q1 		$1.26M Sell
38,860
-34,514
-47% -$1.32M ﹤0.01% 2752
2013
Q4 		$3.09M Sell
73,374
-1,522
-2% -$62.6K ﹤0.01% 2464
2013
Q3 		$2.99M Sell
74,896
-30,185
-29% -$1.27M ﹤0.01% 2532
2013
Q2 		$4.34M Buy
+105,081
New +$4.25M ﹤0.01% 2232

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase's HAE Position: Q1 2026 in Review

JP Morgan Chase increased its Haemonetics (HAE) stake by 28% in Q1 2026, buying an estimated $4.71M and bringing the position to 328,909 shares worth $18.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2161.

JP Morgan Chase first reported a position in HAE in Q2 2013 and has held it in 48 quarters since. The position peaked at $81.3M in Q3 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • JP Morgan Chase held 328,909 shares of Haemonetics worth $18.1M as of Q1 2026.
  • JP Morgan Chase bought 72,356 Haemonetics shares in Q1 2026, an estimated $4.71M.
  • Haemonetics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2161 holding.
  • JP Morgan Chase first reported a position in Haemonetics in Q2 2013 and has held it in 48 quarters since.
  • JP Morgan Chase's Haemonetics position peaked at $81.3M in Q3 2018.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.